Clinical Trial Update: A Clinical Trial Comparing the Efficacy of Darunavir/Ritonavir Monotherapy Versus a Triple Combination Therapy Containing Darunavir/Ritonavir and 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Patients With Undetectable Plasma HIV-1 RNA on Current Treatment [Phase 3]

View source ↗

Summary

A Phase 3 trial compared once-daily darunavir/ritonavir monotherapy to a triple regimen including darunavir/ritonavir in HIV patients with undetectable viral lo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• darunavir/ritonavir (darunavir/ritonavir)

Snippet

Sponsor: Janssen-Cilag International NV | Conditions: Human Immunodeficiency Virus (HIV) Infections, Acquired Immunodeficiency Syndrome (AIDS) Virus | Phase 3 | Status: COMPLETED | Results posted: 2015-12-03